Dr Reddy's Q1 net profit up 45% at Rs 663 cr on rise in generics business

A combination of factors, including an 8% growth in global generics business and the other operating income drove the growth in net profit of Dr Reddy's during the first quarter ended June, 2019

Drug major Dr Reddy's Laboratories Limited has reported a 45.31 per cent jump in consolidated net profit at Rs 662.8 crore for the quarter ended June, 2019 as compared to Rs 456.1 crore in the same quarter previous year. 

The revenues of the company grew by 3 per cent to Rs 3,843.5 crore for the quarter under review, from Rs 3720.7 crore in the corresponding previous quarter

A combination of factors, including an 8 per cent growth in global generics business and the other operating income drove the growth in net profit of Dr Reddy's during the first quarter ended